Qualcomm Upgraded, Meta Downgraded: Top Analyst Calls on Wall Street

Wall Street saw notable analyst rating changes today for several major stocks, including an upgrade for Qualcomm (QCOM) and a downgrade for Meta (META), according to reports from The Fly.

Rating Changes

Qualcomm (QCOM)

• Previous Rating: Neutral
• New Rating: Buy
• New Price Target: $220

Meta (META)

• Previous Rating: Buy
• New Rating: Neutral
• New Price Target: $550

Palantir (PLTR)

• Rating: Price target raised to $35
• Current Rating: Buy

AbbVie (ABBV)

• Rating: Price target lowered to $180
• Current Rating: Buy

Analyst Rationale

The upgrade for Qualcomm was driven by strong expectations for the semiconductor sector, particularly increased demand for 5G chips and smartphones. In contrast, Meta's downgrade stems from concerns over rising investment costs in AI and virtual reality, which could pressure profit margins.

For Palantir, the analyst raised the price target based on growth prospects in government contracts and commercial expansion. Meanwhile, AbbVie's target was cut due to increased competition for its Humira drug.

Context

These changes come at a time of significant volatility in the tech sector, with companies focusing on AI and expansion into emerging markets. Recent stock performance has been mixed: Qualcomm rose about 15% over the past month, while Meta declined 8%.

What to Make of It

These recommendations reflect divergent outlooks for major tech companies. Analysts appear more optimistic about semiconductor firms like Qualcomm and more cautious about advertising and heavy-investment companies like Meta. Investors are encouraged to evaluate these changes in the context of their personal investment strategies.